GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » Cash Conversion Cycle

Safeguard Scientifics (Safeguard Scientifics) Cash Conversion Cycle : 0.00 (As of Dec. 2023)


View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Safeguard Scientifics's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.
Safeguard Scientifics's Days Inventory for the three months ended in Dec. 2023 was 0.
Safeguard Scientifics's Days Payable for the three months ended in Dec. 2023 was 0.
Therefore, Safeguard Scientifics's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 0.00.


Safeguard Scientifics Cash Conversion Cycle Historical Data

The historical data trend for Safeguard Scientifics's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safeguard Scientifics Cash Conversion Cycle Chart

Safeguard Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Safeguard Scientifics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Safeguard Scientifics's Cash Conversion Cycle

For the Asset Management subindustry, Safeguard Scientifics's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Safeguard Scientifics's Cash Conversion Cycle Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Safeguard Scientifics's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Safeguard Scientifics's Cash Conversion Cycle falls into.



Safeguard Scientifics Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Safeguard Scientifics's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=0+0-0
=0.00

Safeguard Scientifics's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=0+0-0
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Safeguard Scientifics  (OTCPK:SFES) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Safeguard Scientifics Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Safeguard Scientifics (Safeguard Scientifics) Business Description

Traded in Other Exchanges
Address
150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087
Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. Safeguard generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders.
Executives
Satterfield Thomas A Jr 10 percent owner 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont director 51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr. director 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Mark Herndon officer: SVP & Chief Financial Officer C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman officer: Chief Restructuring Officer C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert director C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts director 1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko officer: Senior V.P. & General Counsel 435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass director 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille officer: Senior VP & CFO C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison director C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli officer: Acting Sr VP & Acting CFO FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz director P O BOX 738, RYE NH 03870